Covered recipient · General Payments record

PETER G LAPMAN

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI: 1568637858
CMS profile: 207007
Location: NEPTUNE, NJ

General Payments · PY2018–2024

$8,606.44

Reported across 542 records
CMS publication 2026-01-23

Latest program year · PY2024

$1,364.38

73 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$1,364.38	73

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
E.R. Squibb & Sons, L.L.C.	$262.20	12
Novo Nordisk AS	$234.36	11
Amgen Inc.	$218.85	13
NOVARTIS PHARMACEUTICALS CORPORATION	$89.54	6
Merck Sharp & Dohme Corporation	$82.20	5
Abbott Laboratories	$79.44	2
Kiniksa Pharmaceuticals International, plc	$71.45	4
Boehringer Ingelheim Pharmaceuticals, Inc.	$58.54	4
HEARTFLOW, INC.	$53.42	3
Alnylam Pharmaceuticals Inc.	$48.94	3
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)	$45.18	3
CVRx Inc.	$28.73	2
BOSTON SCIENTIFIC CORPORATION	$24.79	1
SANOFI-AVENTIS U.S. LLC	$18.42	1
United Therapeutics Corporation	$17.41	1
PFIZER INC.	$16.24	1
Regeneron Healthcare Solutions, Inc.	$14.67	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$1,353.18	82
PY2019	$1,292.86	75
PY2020	$677.25	48
PY2021	$1,204.68	90
PY2022	$1,453.27	97
PY2023	$1,260.82	77
PY2024	$1,364.38	73

Payment records · PY2024 (73)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
Abbott Laboratories	$53.95	02/29/2024	Food and Beverage	Undisputed	01/23/2026	1125129398	CMS
Abbott Laboratories	$25.49	03/28/2024	Food and Beverage	Undisputed	01/23/2026	1125129400	CMS
Alnylam Pharmaceuticals Inc.	$16.52	06/12/2024	Food and Beverage	Undisputed	01/23/2026	1125831943	CMS
Alnylam Pharmaceuticals Inc.	$16.58	08/14/2024	Food and Beverage	Undisputed	01/23/2026	1125831965	CMS
Alnylam Pharmaceuticals Inc.	$15.84	11/07/2024	Food and Beverage	Undisputed	01/23/2026	1125832021	CMS
Amgen Inc.	$15.29	01/17/2024	Food and Beverage	Undisputed	01/23/2026	1115850558	CMS
Amgen Inc.	$16.28	02/07/2024	Food and Beverage	Undisputed	01/23/2026	1115850567	CMS
Amgen Inc.	$16.57	02/20/2024	Food and Beverage	Undisputed	01/23/2026	1115850576	CMS
Amgen Inc.	$16.91	02/27/2024	Food and Beverage	Undisputed	01/23/2026	1115850584	CMS
Amgen Inc.	$16.76	04/17/2024	Food and Beverage	Undisputed	01/23/2026	1115850602	CMS
Amgen Inc.	$15.98	04/19/2024	Food and Beverage	Undisputed	01/23/2026	1115850593	CMS
Amgen Inc.	$16.27	05/09/2024	Food and Beverage	Undisputed	01/23/2026	1115850609	CMS
Amgen Inc.	$18.54	07/30/2024	Food and Beverage	Undisputed	01/23/2026	1115850628	CMS
Amgen Inc.	$16.84	08/01/2024	Food and Beverage	Undisputed	01/23/2026	1115850618	CMS
Amgen Inc.	$18.19	09/26/2024	Food and Beverage	Undisputed	01/23/2026	1117606616	CMS
Amgen Inc.	$14.36	10/08/2024	Food and Beverage	Undisputed	01/23/2026	1115850636	CMS
Amgen Inc.	$18.41	11/06/2024	Food and Beverage	Undisputed	01/23/2026	1115850643	CMS
Amgen Inc.	$18.45	12/20/2024	Food and Beverage	Undisputed	01/23/2026	1115850654	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$13.36	03/05/2024	Food and Beverage	Undisputed	01/23/2026	1118062185	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$14.05	04/29/2024	Food and Beverage	Undisputed	01/23/2026	1118062187	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$15.42	06/05/2024	Food and Beverage	Undisputed	01/23/2026	1118062189	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$15.71	11/07/2024	Food and Beverage	Undisputed	01/23/2026	1118062191	CMS
Boston Scientific Corporation	$24.79	07/10/2024	Food and Beverage	Undisputed	01/23/2026	1092258591	CMS
CVRx, Inc.	$14.15	05/17/2024	Food and Beverage	Undisputed	01/23/2026	1133234146	CMS
CVRx, Inc.	$14.58	06/19/2024	Food and Beverage	Undisputed	01/23/2026	1133234148	CMS
E.R. Squibb & Sons, L.L.C.	$15.73	01/04/2024	Food and Beverage	Undisputed	01/23/2026	1101421520	CMS
E.R. Squibb & Sons, L.L.C.	$11.97	03/12/2024	Food and Beverage	Undisputed	01/23/2026	1101421532	CMS
E.R. Squibb & Sons, L.L.C.	$11.28	03/27/2024	Food and Beverage	Undisputed	01/23/2026	1101421538	CMS
E.R. Squibb & Sons, L.L.C.	$14.26	04/08/2024	Food and Beverage	Undisputed	01/23/2026	1101421546	CMS
E.R. Squibb & Sons, L.L.C.	$14.38	05/22/2024	Food and Beverage	Undisputed	01/23/2026	1101421550	CMS
E.R. Squibb & Sons, L.L.C.	$12.29	06/18/2024	Food and Beverage	Undisputed	01/23/2026	1101421558	CMS
E.R. Squibb & Sons, L.L.C.	$14.23	08/13/2024	Food and Beverage	Undisputed	01/23/2026	1101421570	CMS
E.R. Squibb & Sons, L.L.C.	$14.61	10/22/2024	Food and Beverage	Undisputed	01/23/2026	1101421576	CMS
E.R. Squibb & Sons, L.L.C.	$5.59	10/24/2024	Food and Beverage	Undisputed	01/23/2026	1101421574	CMS
E.R. Squibb & Sons, L.L.C.	$12.92	11/08/2024	Food and Beverage	Undisputed	01/23/2026	1101421582	CMS
E.R. Squibb & Sons, L.L.C.	$124.09	11/14/2024	Food and Beverage	Undisputed	01/23/2026	1101421604	CMS
E.R. Squibb & Sons, L.L.C.	$10.85	12/19/2024	Food and Beverage	Undisputed	01/23/2026	1101421602	CMS
HEARTFLOW, INC.	$17.40	05/14/2024	Food and Beverage	Undisputed	01/23/2026	1154166384	CMS
HEARTFLOW, INC.	$17.40	06/21/2024	Food and Beverage	Undisputed	01/23/2026	1154166386	CMS
HEARTFLOW, INC.	$18.62	07/22/2024	Food and Beverage	Undisputed	01/23/2026	1154166388	CMS
Kiniksa Pharmaceuticals International, plc	$21.02	02/06/2024	Food and Beverage	Undisputed	01/23/2026	1154878874	CMS
Kiniksa Pharmaceuticals International, plc	$15.75	06/04/2024	Food and Beverage	Undisputed	01/23/2026	1154878898	CMS
Kiniksa Pharmaceuticals International, plc	$16.42	08/02/2024	Food and Beverage	Undisputed	01/23/2026	1154878924	CMS
Kiniksa Pharmaceuticals International, plc	$18.26	09/30/2024	Food and Beverage	Undisputed	01/23/2026	1154879018	CMS
Merck Sharp & Dohme LLC	$13.78	01/29/2024	Food and Beverage	Undisputed	01/23/2026	1141604856	CMS
Merck Sharp & Dohme LLC	$15.86	05/15/2024	Food and Beverage	Undisputed	01/23/2026	1141916439	CMS
Merck Sharp & Dohme LLC	$17.66	08/16/2024	Food and Beverage	Undisputed	01/23/2026	1141838893	CMS
Merck Sharp & Dohme LLC	$17.05	09/16/2024	Food and Beverage	Undisputed	01/23/2026	1141604858	CMS
Merck Sharp & Dohme LLC	$17.85	11/25/2024	Food and Beverage	Undisputed	01/23/2026	1141838889	CMS
Novartis Pharmaceuticals Corporation	$14.78	01/08/2024	Food and Beverage	Undisputed	01/23/2026	1087084686	CMS
Novartis Pharmaceuticals Corporation	$13.07	04/04/2024	Food and Beverage	Undisputed	01/23/2026	1087084688	CMS
Novartis Pharmaceuticals Corporation	$17.72	06/11/2024	Food and Beverage	Undisputed	01/23/2026	1087084694	CMS
Novartis Pharmaceuticals Corporation	$13.32	06/25/2024	Food and Beverage	Undisputed	01/23/2026	1087084696	CMS
Novartis Pharmaceuticals Corporation	$16.08	07/16/2024	Food and Beverage	Undisputed	01/23/2026	1087084700	CMS
Novartis Pharmaceuticals Corporation	$14.57	10/23/2024	Food and Beverage	Undisputed	01/23/2026	1087084704	CMS
Novo Nordisk Inc	$10.58	03/15/2024	Food and Beverage	Undisputed	01/23/2026	1096566676	CMS
Novo Nordisk Inc	$2.25	03/15/2024	Food and Beverage	Undisputed	01/23/2026	1097508682	CMS
Novo Nordisk Inc	$14.13	04/12/2024	Food and Beverage	Undisputed	01/23/2026	1097003360	CMS
Novo Nordisk Inc	$16.31	05/21/2024	Food and Beverage	Undisputed	01/23/2026	1096908389	CMS
Novo Nordisk Inc	$13.50	06/17/2024	Food and Beverage	Undisputed	01/23/2026	1096613236	CMS
Novo Nordisk Inc	$13.46	07/18/2024	Food and Beverage	Undisputed	01/23/2026	1096889670	CMS
Novo Nordisk Inc	$9.05	08/02/2024	Food and Beverage	Undisputed	01/23/2026	1097518476	CMS
Novo Nordisk Inc	$117.76	08/07/2024	Food and Beverage	Undisputed	01/23/2026	1097179531	CMS
Novo Nordisk Inc	$15.95	10/29/2024	Food and Beverage	Undisputed	01/23/2026	1096995954	CMS
Novo Nordisk Inc	$4.67	11/18/2024	Food and Beverage	Undisputed	01/23/2026	1097200818	CMS
Novo Nordisk Inc	$16.70	12/04/2024	Food and Beverage	Undisputed	01/23/2026	1096573418	CMS
PFIZER INC.	$16.24	12/03/2024	Food and Beverage	Undisputed	01/23/2026	1131013227	CMS
Regeneron Healthcare Solutions, Inc.	$14.67	07/25/2024	Food and Beverage	Undisputed	01/23/2026	1114096183	CMS
SANOFI-AVENTIS U.S. LLC	$18.42	06/13/2024	Food and Beverage	Undisputed	01/23/2026	1139760192	CMS
United Therapeutics Corporation	$17.41	11/22/2024	Food and Beverage	Undisputed	01/23/2026	1149459382	CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)	$15.06	01/05/2024	Food and Beverage	Undisputed	01/23/2026	1080679870	CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)	$15.06	01/30/2024	Food and Beverage	Undisputed	01/23/2026	1080679900	CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)	$15.06	02/29/2024	Food and Beverage	Undisputed	01/23/2026	1080679938	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.